查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609967

血浆分馏市场规模、份额、趋势分析报告：按产品、方法、应用、最终用途、地区和细分市场预测，2025-2030 年

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

血浆分馏市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年，全球血浆分馏市场规模将达到 582.4 亿美元，并且预计 2025 年至 2030 年复合年增长率为 8.5%。

推动市场成长的主要因素是全球呼吸系统疾病、血液相关疾病的盛行率上升，以及更容易罹患各种罕见疾病的人口老化。这些都是市场拓展的主要因素。此外，需要血浆治疗和衍生物的罕见疾病的盛行率不断上升也补充了市场的成长。

此外，免疫球蛋白和α-1-抗胰蛋白酶目前正被用于世界各地的各个研究领域，为全球市场的扩张做出了贡献。市场扩张的另一个重要因素是全球采血设施的增加。例如，根据世界卫生组织统计，截至2022年5月，全球已有超过1.18亿人捐血，血浆供应量逐渐增加。此外，政府提高民众对血浆衍生产品使用意识的支持措施也是全球市场扩张的主要动力。

血浆输注是治疗 COVID-19 感染的最先进治疗之一。例如，2020 年 8 月，美国食品药物管理局(USFDA) 向 COVID-19 恢復期血浆疗法授予紧急使用核准(EUA)。此外，2021 年 2 月，我们宣布了一项关于针对 COVID-19 的血浆 EUA 的修订指令。因此，在 COVID-19 大流行期间，血浆分馏技术的使用预计会增加。

由于个人化治疗的需求不断增长，研发成本不断增加，而免疫血清球蛋白等血浆成分的技术进步，具有产量高、成本低、通量快等优势，是增加市场的驱动力。 。另一方面，由血浆产生的免疫球蛋白更频繁地用于各种临床病症，包括自体免疫疾病和发炎性疾病。胞浆素、IgA 和胞浆素等治疗药物已从血浆分馏领域获得了大量资金。此外，该行业正在受到创新和技术开发投资增加的推动，这些投资提供了高效且廉价的蛋白质分离方法。

这个市场为企业开展市场相关业务提供了许多机会。此外，随着市场的稳定扩大，全球各地区的市场参与企业在积极实施有机和无机的发展策略。因此，预计市场在预测期内将吸引更多引人注目的投资。例如，2022 年 1 月，Biotest AG 在捷克共和国开设了第八个血浆采集设施。该国公共卫生当局 SUKL 已授予该公司经营这些中心的许可证。

血浆分馏市场报告亮点

  • 免疫球蛋白领域预计将在 2024 年以 63.2% 的收益占有率主导市场，并以 9.1% 的复合年增长率增长最快。
  • 层析法细分市场占据主导地位，到 2024 年，其份额将达到 33.7%。血浆分馏的精製技术以及工业规模层析法分离的使用最近有所增加。
  • 由于人们对神经系统疾病血浆衍生疗法的认识不断提高，神经学领域在 2024 年占据了最大的销售份额，达到 30.0%。多发性硬化症、Guillain-Barré二氏症候群和慢性脱髓鞘多发性神经炎等疾病越来越多地采用静脉免疫球蛋白疗法 (IVIg) 和血浆置换等疗法进行治疗。
  • 医院和诊所在2024年占据市场主导地位，收益占有率53.4%，预计在预测期内将以9.0%的最快复合年增长率增长。这是由于各种医疗应用对血浆衍生疗法的需求不断增长所推动的。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章血浆分馏市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 血浆分馏市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章血浆分馏市场：按产品分类的估计和趋势分析

  • 细分仪表板
  • 全球血浆分馏市场产品波动分析
  • 2018-2030 年全球血浆分馏市场规模及趋势分析（依产品）
  • 白蛋白
  • 免疫球蛋白
    • 静脉注射免疫球蛋白
    • 皮下注射免疫球蛋白
    • 其他免疫球蛋白
  • 凝血因子
    • 因子VIII
    • 因子IX
    • 血管性血友病因子
    • 凝血酶原复合物浓缩物
    • 纤维蛋白原浓缩物
    • 其他的
  • 蛋白酶抑制剂
  • 其他的

第五章血浆分馏市场：方法估计与趋势分析

  • 细分仪表板
  • 全球血浆分馏市场波动分析
  • 2018-2030 年全球血浆分馏市场规模及趋势分析（依方法）
  • 离心
  • 深层过滤
  • 层析法
  • 其他的

第六章血浆分馏市场：依应用估算与趋势分析

  • 细分仪表板
  • 全球血浆分馏市场应用变迁分析
  • 2018-2030 年全球血浆分馏市场规模及趋势分析（依应用）
  • 神经病学
  • 血液学
  • 肿瘤学
  • 免疫学
  • 呼吸系统医疗设备
  • 其他的

第七章血浆分馏市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球血浆分馏市场的最终用途变化分析
  • 2018-2030 年全球血浆分馏市场规模与趋势分析（依最终用途）
  • 医院/诊所
  • 临床调查
  • 其他的

第八章血浆分馏市场：区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2024 年企业市场分析
  • 公司简介
    • Grifols SA
    • CSL Limited
    • Takeda Pharmaceutical Company Limited
    • Octapharma AG
    • Kedrion SpA
    • LFB SA
    • Biotest AG
    • Sanquin
    • Bio Products Laboratory Ltd.
    • Intas Pharmaceuticals Ltd
Product Code: GVR-4-68039-962-8

Plasma Fractionation Market Growth & Trends:

The global plasma fractionation market size is estimated to reach USD 58.24 billion by 2030, registering to grow at a CAGR of 8.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market growth are the rising prevalence of respiratory illnesses globally, blood-related diseases, and an aging population that is prone to a variety of rare disorders. These are the main drivers of market expansion. In addition, the rise in the prevalence of rare disorders that call for plasma therapy or derivatives also supplemented the market growth.

The global market is also expanding due to the increased use of immunoglobulins as well as alpha-1-antitrypsin in various areas of research around the world. Another important factor for the expansion of the market is the rise in blood collection facilities globally. For instance, as per the WHO, as of May 2022, over 118 million blood donations were collected across the globe, thus increasing the plasma supply gradually. Additionally, supportive government initiatives to raise public awareness about the usage of plasma-derived products also serve as a major driver of the global market's expansion.

Blood plasma transfusions are one of the cutting-edge treatments for COVID-19 infection. For instance, in August 2020, the US Food and Drug Administration (USFDA) granted the convalescent plasma treatment of COVID-19 an emergency use authorization (EUA). Additionally, in February 2021, it published an amended directive for the plasma EUA for COVID-19. As a result, the usage of plasma fractionation technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medications has increased R&D spending, and technological advancements in plasma components such as immune serum globulin, which have advantages such as higher yield, lower cost, and faster throughput, are driving market growth. On the other hand, immunoglobulins generated from plasma are being employed more frequently for a variety of clinical conditions, including autoimmune and inflammatory illnesses. Therapies including Ceruloplasmin, IgA, and Plasmin have received significant funding from the plasma fractionation sector. Additionally, the industry will receive a boost from booming investments in innovation and technology developments that result in efficient and affordable methods for fractionating proteins. thus, propelling the market's growth.

For companies operating market-related businesses, the market offers a lot of opportunities. In addition, the global and regional market participants are actively implementing organic and inorganic development strategies as a result of the market's favorable expansion. As a result, it is anticipated that the market will draw more notable investments during the forecast period. For instance, in January 2022, the eighth plasma collection facility in the Czech Republic was opened by Biotest AG. The national public health authority, SUKL, granted the company an operating license for these centers.

Plasma Fractionation Market Report Highlights:

  • The immunoglobulins segment dominated the market in terms of revenue share of 63.2% in 2024 and is anticipated to grow at the fastest CAGR of 9.1%. fueled by its widespread use in treating immune deficiencies, autoimmune diseases, and neurological disorders.
  • The chromatography segment dominated the market and accounted for a 33.7% share in 2024. The utilization of industrial-scale chromatographic fractionation as well as purification techniques for plasma fractionation has increased recently.
  • The neurology segment held the largest revenue share of 30.0% in 2024, driven by the increasing recognition of plasma-derived therapies for neurological disorders. Conditions such as multiple sclerosis, Guillain-Barre syndrome, and chronic inflammatory demyelinating polyneuropathy are increasingly being treated with therapies like intravenous immunoglobulin (IVIg) and plasmapheresis.
  • The hospitals and clinics dominated the market with the largest revenue share of 53.4% in 2024 and are expected to grow at the fastest CAGR of 9.0% over the forecast period. This is driven by the increasing demand for plasma-derived therapies in various medical applications.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing Demand For Advanced Treatment Options To Boost Market Growth
      • 3.2.1.2. Growing Use Of Immunoglobulins In Various Therapeutic Areas
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Regulatory Policies
  • 3.3. Plasma Fractionation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Plasma Fractionation Market Product Movement Analysis
  • 4.3. Global Plasma Fractionation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Billion)
  • 4.4. Albumin
    • 4.4.1. Albumin market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Immunoglobulins
    • 4.5.1. Immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Intravenous immunoglobulins
      • 4.5.2.1. Intravenous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Subcutaneous immunoglobulins
      • 4.5.3.1. Subcutaneous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Other immunoglobulins
      • 4.5.4.1. Other immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Coagulation Factors
    • 4.6.1. Coagulation factors market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.2. Factor VIII
      • 4.6.2.1. Factor VIII market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.3. Factor IX
      • 4.6.3.1. Factor IX market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.4. VON WILLEBRAND factor
      • 4.6.4.1. VON WILLEBRAND factor market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.5. Prothrombin complex concentrates
      • 4.6.5.1. Prothrombin complex concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.6. Fibrinogen concentrates
      • 4.6.6.1. Fibrinogen concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.7. Others
      • 4.6.7.1. Others factor market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Protease inhibitors
    • 4.7.1. Protease inhibitors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Plasma Fractionation Market Method Movement Analysis
  • 5.3. Global Plasma Fractionation Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Billion)
  • 5.4. Centrifugation
    • 5.4.1. Centrifugation market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Depth Filtration
    • 5.5.1. Depth filtration market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Chromatography
    • 5.6.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Plasma Fractionation Market Application Movement Analysis
  • 6.3. Global Plasma Fractionation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Neurology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Hematology
    • 6.5.1. Hematology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Oncology
    • 6.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Immunology
    • 6.7.1. Immunology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.8. Pulmonology
    • 6.8.1. Pulmonology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Plasma Fractionation Market End-use Movement Analysis
  • 7.3. Global Plasma Fractionation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Billion)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5. Clinical Research
    • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Grifols S.A.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. CSL Limited
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Takeda Pharmaceutical Company Limited
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Octapharma AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Kedrion S.p.A
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. LFB S.A.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Biotest AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Sanquin
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Bio Products Laboratory Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Intas Pharmaceuticals Ltd
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global plasma fractionation market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 5 Global plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 North America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 10 North America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 11 North America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 U.S. plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 13 U.S. plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 14 U.S. plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.S. plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Canada plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 17 Canada plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 18 Canada plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Canada plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Mexico plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 21 Mexico plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 22 Mexico plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Mexico plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Europe plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 26 Europe plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 27 Europe plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Europe plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 UK plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 30 UK plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 31 UK plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 32 UK plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Germany plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Germany plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 35 Germany plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Germany plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 France plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 38 France plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 39 France plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 40 France plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Italy plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 42 Italy plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 43 Italy plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Italy plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Spain plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Spain plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 47 Spain plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Spain plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Denmark plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 50 Denmark plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 51 Denmark plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Denmark plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 53 Sweden plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 54 Sweden plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 55 Sweden plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Sweden plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Norway plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Norway plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 59 Norway plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 60 Norway plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Japan plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 67 Japan plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 68 Japan plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Japan plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70 China plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 71 China plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 72 China plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 73 China plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 India plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 75 India plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 76 India plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 77 India plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 78 Australia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 79 Australia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 80 Australia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 81 Australia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 82 South Korea plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 83 South Korea plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 84 South Korea plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 85 South Korea plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86 Thailand plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 87 Thailand plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 88 Thailand plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Thailand plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 Latin America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 92 Latin America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 93 Latin America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 94 Latin America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 95 Brazil plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 96 Brazil plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 97 Brazil plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 98 Brazil plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 99 Argentina plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 100 Argentina plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 101 Argentina plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 102 Argentina plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 103 MEA plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 105 MEA plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 106 MEA plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 107 MEA plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 108 South Africa plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 109 South Africa plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 110 South Africa plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 111 South Africa plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 116 UAE plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 117 UAE plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 118 UAE plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 119 UAE plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Plasma fractionation market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Plasma fractionation market: Product outlook key takeaways
  • Fig. 20 Plasma fractionation market: Product movement analysis
  • Fig. 21 Albumin market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Intravenous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Subcutaneous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Other immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Coagulation Factors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Factor IX market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 VON WILLEBRAND factor market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Prothrombin complex concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Fibrinogen concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Protease inhibitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Plasma fractionation market: Method outlook key takeaways
  • Fig. 36 Plasma fractionation market: Method movement analysis
  • Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Depth Filtration market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Chromatography market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Plasma fractionation market: Application outlook key takeaways
  • Fig. 42 Plasma fractionation market: Application movement analysis
  • Fig. 43 Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Hematology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Pulmonology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Plasma fractionation market: End-use outlook key takeaways
  • Fig. 50 Plasma fractionation market: End-use movement analysis
  • Fig. 51 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Regional marketplace outlook, 2024 & 2030 (USD Billion)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 North America plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 U.S. plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 Canada plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Mexico plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Europe plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Key country dynamics
  • Fig. 67 Germany plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 France plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 Sweden plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 Norway plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Asia Pacific plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 Japan plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 China plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key country dynamics
  • Fig. 86 India plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Korea plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Thailand plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 Market participant categorization
  • Fig. 95 Plasma fractionation market position analysis, 2024
  • Fig. 96 Strategic framework